Skip to main content

Table 1 Details of the in-depth discussion with various stakeholders that participated in the study

From: Treatment and disposal practices of pharmaceutical effluent containing potential antibiotic residues in two states in India and perceptions of various stakeholders on contribution of pharmaceutical effluent to antimicrobial resistance: a qualitative study

Stakeholder

Region

Organization

Respondent

Mode of interview

Duration of interview (min)

Regulatory bodies

Centre

CPCB

Chairman, Additional Director

Online

20

Haryana

SPCB

Scientific engineer

Face to face interview

40

Telangana

SPCB

Chief environmental engineer

Face to face interview

60

Civic body

Hyderabad

Municipal Cooperation

Chief general manager, Assistant of Chief general manager

Face to face interview

60, 15

Pharmaceutical associations

Haryana

Pharmaceutical manufacturer association of a city

President, Secretary, Member

Face to face interview

70

Hyderabad

Bulk drug manufacturer association

Executive director

Face to face interview

80

Mumbai

Organization of Pharmaceutical Producer of India

Director General and Senior Director of Communication and Patient Advocacy

Online

60

Mumbai

Indian Pharmaceutical Alliance

Secretary general and Member

Online

60

Antibiotic manufacturing pharmaceutical companies

Haryana

Small-scale Indian formulation company (manufacturing injectable beta and non-beta lactam)

Owner & quality control officer

Face to face interview

70

Medium-scale Indian formulation company (manufacturing oral non-beta lactam antibiotics)

Promoter

Face to face interview

75

Large-scale Indian API manufacturing company

Technical director

Face to face interview

80

Large-scale Indian API manufacturing company

Managing director

Face to face interview

70

Multinational API manufacturing company

Technical operations manager, co-operate sustainability officer, quality control officer and waste management officer

Face to face interview

80

Telangana

Medium-scale Indian formulation company

Head of Formulation/Deputy general manager

Face to face interview

70

Multinational API & formulation company

Associate vice-president

Face to face interview

75

Multinational API manufacturing company

Plant manager, chemical engineer and a safety respondent

Face to face interview

80

Civil society

Delhi

Centre for Science & Environment

Program Director

Face to face interview

70

  1. CPCB Central Pollution Control Board; SPCB State Pollution Control Board; API Active Pharmaceutical Ingredient